Help us improve by providing feedback or contacting help@jisc.ac.uk
A F

Alexandra Freeman

Employment

OrganisationRoleDepartmentStart dateEnd date
University of CambridgeExecutive DirectorNot specified2016-10
BBCResearcher, Producer/Director, Series ProducerNot specified2000-012016-10

Education

OrganisationDegree/titleDepartmentStart dateEnd date
University of OxfordDPhil (thesis title: Butterflies as Signal Receivers)Not specified19951998
University of OxfordBiological Sciences with Supplementary Biological AnthropologyNot specified19921995

Works

TitleDOIPublished date
Do colored cells in risk matrices affect decision-making and risk perception? Insights from randomized controlled studies10.1111/risa.140912023
COVID-19 risk perception and hoax beliefs in the US immediately before and after the announcement of President Trump's diagnosis10.1098/rsos.2120132022
Investigating the presentation of uncertainty in an icon array: A randomized trial10.1016/j.pecinn.2021.1000032022
Making BRCA1 genetic test reports easier to understand through user-centered design: A randomized trial10.1016/j.gim.2022.04.0162022
The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis10.1371/journal.pone.02753212022
The effects of communicating scientific uncertainty on trust and decision making in a public health contextNo DOI available.2022
Expert elicitation on the relative importance of possible SARS-CoV-2 transmission routes and the effectiveness of mitigations.10.1136/bmjopen-2021-0508692021-12
The effects of President Trump’s COVID-19 diagnosis on hoax beliefs and risk perceptions of the virus in the U.S.10.31234/osf.io/frxt82021-12
Visualising SARS-CoV-2 transmission routes and mitigations.10.1136/bmj-2021-0653122021-12
The effects of quality of evidence communication on perception of public health information about COVID-19: Two randomised controlled trials.10.1371/journal.pone.02590482021-11
Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial.10.1016/j.eururo.2021.08.0012021-09
How People Understand Risk Matrices, and How Matrix Design Can Improve their Use: Findings from Randomized Controlled Studies.10.1111/risa.138222021-09
The effects of communicating uncertainty around statistics on public trust: an international study10.1101/2021.09.27.212642022021-09
How Accurate Are Accuracy-Nudge Interventions? A Preregistered Direct Replication of Pennycook et al. (2020).10.1177/095679762110245352021-06
Redevelopment of the Predict: Breast Cancer website and recommendations for developing interfaces to support decision-making.10.1002/cam4.40722021-06
How do the UK public interpret COVID-19 test results? Comparing the impact of official information about results and reliability used in the UK, USA and New Zealand: a randomised controlled trial.10.1136/bmjopen-2020-0477312021-05
How well did experts and laypeople forecast the size of the COVID-19 pandemic?10.1371/journal.pone.02509352021-05
Communicating personalized risks from COVID-19: guidelines from an empirical study.10.1098/rsos.2017212021-04
Effect of Information about COVID-19 Vaccine Effectiveness and Side Effects on Behavioural Intentions: Two Online Experiments10.3390/vaccines90403792021-04
The effects of quality of evidence communication on perception of public health information about COVID-19: two randomised controlled trials10.1101/2021.04.07.212550102021-04
The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis.10.1371/journal.pone.02464412021-02
Clinical impact of the <i>Predict</i> Prostate risk communication tool in men newly diagnosed with non-metastatic prostate cancer: a multi-centre randomised controlled trial10.1101/2021.01.24.212499482021-01
COVID-19 risk perception: a longitudinal analysis of its predictors and associations with health protective behaviours in the United Kingdom10.1080/13669877.2021.18906372021
Correlates of intended COVID-19 vaccine acceptance across time and countries: Results from a series of cross-sectional surveys10.1136/bmjopen-2020-0480252021
Effect of information format on intentions and beliefs regarding diagnostic imaging for non-specific low back pain: A randomised controlled trial in members of the public10.1016/j.pec.2020.08.0212021
How do the public interpret COVID-19 swab test results? Comparing the impact of official information about results and reliability used in the UK, US and New Zealand: a randomised, controlled trial10.1101/2020.12.04.202438402020-12
Predictors of COVID-19 vaccine acceptance across time and countries10.1101/2020.12.09.202464392020-12
Five rules for evidence communication.10.1038/d41586-020-03189-12020-11
Communicating personalised risks from COVID-19: guidelines from an empirical study10.1101/2020.10.05.202069612020-10
Susceptibility to misinformation about COVID-19 around the world.10.1098/rsos.2011992020-10
Teaching clinicians shared decision making and risk communication online: an evaluation study.10.1136/bmjebm-2020-1115212020-09
Communicating risks and benefits to cardiology patients.10.1136/heartjnl-2020-3175932020-08
The effects of communicating uncertainty on public trust in facts and numbers.10.1073/pnas.19136781172020-03
Recommendations for designing genetic test reports to be understood by patients and non-specialists.10.1038/s41431-020-0579-y2020-02
Making prognostic algorithms useful in shared decision-making: Patients and clinicians’ requirements for the Predict:Breast Cancer interface10.1101/2020.11.16.202323482020
Risk communication in tables versus text: A registered report randomized trial on 'fact boxes'10.1098/rsos.1908762020
Risk perceptions of COVID-19 around the world10.1080/13669877.2020.17581932020
Correction: Creating genetic reports that are understood by nonspecialists: a case study.10.1038/s41436-019-0663-22019-09
Creating genetic reports that are understood by nonspecialists: a case study.10.1038/s41436-019-0649-02019-09
How to communicate evidence to patients.10.1136/dtb.2019.0000082019-08
Communicating uncertainty about facts, numbers and science.10.1098/rsos.1818702019-05
Communicating health risks in science publications: time for everyone to take responsibility.10.1186/s12916-018-1194-42018-11
Winners and losers: communicating the potential impacts of policies10.1057/s41599-018-0121-92018-06
Communicating risk in primary care: what the Academy of Medical Sciences' report means in practice.10.3399/bjgp17x6917932017-08
PROMIS - Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer10.1016/j.cct.2015.02.0082015
First authentic capture of a coelacanth, Latimeria chalumnae (Pisces: Latimeriidae), off MadagascarNo DOI available.1996
The evolution of self-concealed ovulation in humans10.1016/0162-3095(95)00071-21995

Octopus publications